115 related articles for article (PubMed ID: 28781635)
1. Wip1 gene silencing enhances the chemosensitivity of human colon cancer cells.
Xia ZS; Wu D; Zhong W; Lu XJ; Yu T; Chen QK
Oncol Lett; 2017 Aug; 14(2):1875-1883. PubMed ID: 28781635
[TBL] [Abstract][Full Text] [Related]
2. Wip1 regulates SKOV3 cell apoptosis through the p38 MAPK signaling pathway.
Feng Y; Liu F; Du Z; Zhao D; Cheng J; Guo W
Mol Med Rep; 2017 Jun; 15(6):3651-3657. PubMed ID: 28440479
[TBL] [Abstract][Full Text] [Related]
3. p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors.
Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J
Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851
[TBL] [Abstract][Full Text] [Related]
4. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
5. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON
Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811
[TBL] [Abstract][Full Text] [Related]
6. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of WIP1 in A549 cells enhances the sensitivity of cells to arsenic treatment].
Luo Q; Gu S; Zhang Z
Wei Sheng Yan Jiu; 2017 May; 46(3):389-395. PubMed ID: 29903248
[TBL] [Abstract][Full Text] [Related]
8. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
Long X; Lin XJ
J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-16 sensitizes drug-resistant breast cancer cells to Adriamycin by targeting Wip1 and Bcl-2.
Gao X; Wang M; Zhang Y; Xu Z; Ding J; Tang J
Oncol Lett; 2019 Sep; 18(3):2897-2906. PubMed ID: 31452770
[TBL] [Abstract][Full Text] [Related]
10. p38 MAPK signaling pathway activation by phenyl benzoxime in SNU-306 cells causes induction of apoptosis.
Chen W; Tan Y; Zhang Y
Microb Pathog; 2019 Jan; 126():74-78. PubMed ID: 30347260
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract][Full Text] [Related]
12. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation.
Takekawa M; Adachi M; Nakahata A; Nakayama I; Itoh F; Tsukuda H; Taya Y; Imai K
EMBO J; 2000 Dec; 19(23):6517-26. PubMed ID: 11101524
[TBL] [Abstract][Full Text] [Related]
13. The Regulation of Trophoblastic p53 Homeostasis by the p38-Wip1 Feedback Loop is Disturbed in Placentas from Pregnancies Complicated by Preeclampsia.
Tan B; Tong C; Yuan Y; Xu P; Wen L; Zhang C; Zheng Y; Lin L; Zhu F; Gui S; Wang L; Gao R; Li J; Qi H; Baker PN
Cell Physiol Biochem; 2019; 52(2):315-335. PubMed ID: 30816677
[TBL] [Abstract][Full Text] [Related]
14. Stable reversal of multidrug resistance in colon cancer cells by RNA interference targeting the MDR1 gene.
Xia Z; Zhang L; Chen Q; Royal C; Yu Z; Liu Z; Adam BL
Mol Med Rep; 2009; 2(4):579-84. PubMed ID: 21475869
[TBL] [Abstract][Full Text] [Related]
15. WIP1 phosphatase as a potential therapeutic target in neuroblastoma.
Richter M; Dayaram T; Gilmartin AG; Ganji G; Pemmasani SK; Van Der Key H; Shohet JM; Donehower LA; Kumar R
PLoS One; 2015; 10(2):e0115635. PubMed ID: 25658463
[TBL] [Abstract][Full Text] [Related]
16. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
17. Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma.
Fuku T; Semba S; Yutori H; Yokozaki H
Pathol Int; 2007 Sep; 57(9):566-71. PubMed ID: 17685927
[TBL] [Abstract][Full Text] [Related]
18. Expression and significance of the Wip1 proto-oncogene in colorectal cancer.
Li ZT; Zhang L; Gao XZ; Jiang XH; Sun LQ
Asian Pac J Cancer Prev; 2013; 14(3):1975-9. PubMed ID: 23679302
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
Qi X; Chang Z; Song J; Gao G; Shen Z
Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
[TBL] [Abstract][Full Text] [Related]
20. Wip1 deficiency impairs haematopoietic stem cell function via p53 and mTORC1 pathways.
Chen Z; Yi W; Morita Y; Wang H; Cong Y; Liu JP; Xiao Z; Rudolph KL; Cheng T; Ju Z
Nat Commun; 2015 Apr; 6():6808. PubMed ID: 25879755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
